SQZ Biotechnologies Growth, Revenue, Number of Employees and Funding

Overview

Location:
Boston, MA USA
Total Funding:$102.1M
Industry:Biotech
Founded:2013
Lead Investor(s):JDRF T1D Fund.
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • SQZ Biotechnologies's estimated revenue is currently $16.4M per year.
  • SQZ Biotechnologies received $72.0M in venture funding in August 2018.
  • SQZ Biotechnologies's estimated revenue per employee is $145398
  • SQZ Biotechnologies's total funding is $102.1M.

Employee Data

  • SQZ Biotechnologies has 113 Employees.
  • SQZ Biotechnologies grew their employee count by 23% last year.
  • SQZ Biotechnologies currently has 15 job openings.

Executive Contacts

NameTitle
Ashley JonesSr. Director of Culture & People
Volker HerrmannCVOO & President
David ChirgwinAssociate Director - Process Development and Manufacturing
Benjamin GreenbergDirector, Strategic Clinical Sourcing
Aaron HandlerAssociate Director, Analytical Development & Quality Control
Tia DiTommasoAssociate Director, Strategic Partnerships and Exploratory
Ipsita RoymoulikSenior Director Analytical Development & Quality Control
Scott LoughheadAssociate Director
Howard BernsteinChief Scientific Officer
James DouberleyDirector Of Operations

What Is SQZ Biotechnologies?

SQZ Biotech is a unique cell therapy company, utilizing the proprietary CellSqueeze® platform to develop a new generation of cell therapies. SQZ currently focuses on the development of novel treatments that leverage targeted immune modulation to impact oncology and autoimmune diseases. SQZ: Empower cells to change lives.

keywords:Biotechnology,Healthcare,Pharmaceuticals

113

Number of Employees

$16.4M

Revenue (est)

15

Current Jobs

23%

Employee Growth %

$102.1M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$6.7M4659%
Tango Therapeut...
$8.4M5841%$55M
Compass Therape...
$14.7M10215%
Hamilton Storag...
$13.6M949%
Alnylam Pharmac...
$74.9M122831%$417.5M
Axcella
$8.2M5719%
Berkshire Corpo...
$10.7M7412%
Repligen Corpor...
$47M32422%$242.6M
Allena Pharmace...
$6M5019%$93M
ABclonal Techno...
$7.9M5531%

SQZ Biotechnologies News

09/03/2019 - Merck's head of IR departs to take up finance chief role at SQZ ...

Teri Loxam is leaving her role as head of IR at Merck to become the chief financial officer at SQZ Biotechnologies, a private firm focused on ...

06/25/2019 - Erytech Pharma SA bags US$57m from SQZ Biotechnologies

Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to ... Erytech will licence the rights to use its ERYCAPS platform to SQZ, which ...

09/03/2019 - SQZ Biotech Announces Appointment of Experienced ...

SQZ Biotech Announces Appointment of Experienced Pharmaceutical Executive Teri Loxam as Chief Financial Officer ...

SQZ Biotechnologies Funding

DateAmountRoundLead InvestorsReference
2015-06-25$5.0MAPolaris PartnersArticle
2016-10-03$16.0MUndisclosedNanoDimensionArticle
2016-12-05$4.0MBQuark Venture IncArticle
2017-12-06$UndisclosedUndisclosedJDRF T1D Fund.Article
2018-08-09$72.0MCMultipleArticle

SQZ Biotechnologies Executive Hires

DateNameTitleReference
2016-10-03Kris ElverumChief Business OfficerArticle
2017-08-24Shefali AgarwalChief Medical OfficerArticle
2018-10-08Volker Herrmannchief operating officer and presidentArticle
2019-01-18Oliver RosenChief Medical OfficerArticle